Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06884202 · ClinicalTrials.gov registry record · NA
Evaluation of Delefilcon A Contact Lenses
A NA study, sponsored by Alcon Research.
- Completed
- Registry status
- NA
- Development phase
- 257
- Enrollment target
NCT06884202: Completed NA study, sponsored by Alcon Research.
NCT06884202 is a NA study that has completed, run by Alcon Research. The registered enrollment target is 257 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06884202, a NA study, has completed, sponsored by Alcon Research.
- COMPLETED
- Registry status
- NA
- Development phase
- 257 participants
- Enrollment target
Study Summary
The purpose of the study is to evaluate the lens fit characteristics of delefilcon A contact lenses with different base curves and diameters.
Primary Outcome
Lens movement was evaluated by the investigator using a slit lamp with the eye in primary gaze (looking straight ahead). Subject was asked to blink after which the investigator pushed up the lower lid margin to evaluate lens movement. Lens movement was graded on a 5-point scale as follows: -2 = unacceptably tight (reduced movement, unacceptable); -1 = Acceptably tight (reduced movement, acceptable); 0 = Optimal fit / movement; +1 = Acceptably loose (excessive movement, acceptable); +2 = Unaccept
Interventions
- DEVICE Delefilcon A contact lenses with different base curves and diameters
- DEVICE Delefilcon A contact lenses with standard base curves and diameters
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 257 participants |
| Start Date | 2025-04-28 |
| Est. Completion | 2025-08-26 |
| Phase | NA |
What the finished NCT06884202 record still lists
NCT06884202 is an interventional study that assigns participants to a tested intervention. The registered 257 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (82% lower).
The record links to 0 conditions, and to 2 interventions - of which Delefilcon A contact lenses with different base curves and diameters is the first listed.
NCT06884202 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06884202 about?
NCT06884202 is a clinical study titled "Evaluation of Delefilcon A Contact Lenses". The purpose of the study is to evaluate the lens fit characteristics of delefilcon A contact lenses with different base curves and diameters.
What is the current status of trial NCT06884202?
This trial is currently completed. It is a NA study. The enrollment target is 257 participants. The study started on 2025-04-28. Estimated completion is 2025-08-26.
What interventions are being tested in trial NCT06884202?
The interventions under investigation include: Delefilcon A contact lenses with different base curves and diameters (DEVICE), Delefilcon A contact lenses with standard base curves and diameters (DEVICE).
Who is sponsoring clinical trial NCT06884202?
This trial is sponsored by Alcon Research, which has 275 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT06884202's enrollment target sits among peer trials
257 403rd of 2000 higher than 1,597 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03618550 · 257 participants · Phase 2
Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma
- NCT04674267 · 257 participants · NA
Resilience and Equity in Aging, Cancer, and Health (REACH)
- NCT06099288 · 257 participants · NA
Strong Families Start at Home/Familias Fuertes Comienzan en Casa
- NCT06207084 · 257 participants · NA
The Fit With Us Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI